CN Patent

CN104523590B — 一种丁酸氯维地平脂肪乳注射液

Assigned to Shandong Weigao Pharmaceutical Co Ltd · Expires 2017-09-15 · 9y expired

What this patent protects

一种丁酸氯维地平脂肪乳注射液，涉及丁酸氯维地平药物制剂领域，该注射液包括丁酸氯维地平以及金属螯合剂依地酸二钠。金属螯合剂依地酸二钠比例为0.0001至0.0009% w/v。本发明在保证药品质量的前提下大大降低了金属螯合剂依地酸二钠的用量，增加了药物的安全性与稳定性。

USPTO Abstract

一种丁酸氯维地平脂肪乳注射液，涉及丁酸氯维地平药物制剂领域，该注射液包括丁酸氯维地平以及金属螯合剂依地酸二钠。金属螯合剂依地酸二钠比例为0.0001至0.0009% w/v。本发明在保证药品质量的前提下大大降低了金属螯合剂依地酸二钠的用量，增加了药物的安全性与稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN104523590B
Jurisdiction
CN
Classification
—
Expires
2017-09-15
Drug substance claim
No
Drug product claim
No
Assignee
Shandong Weigao Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.